Valuation: Zenotech Laboratories Limited

Market Cap 2.09B 21.96M 19.02M 17.79M 16.26M 30.62M 31.13M 208M 81.76M 1.05B 82.44M 80.66M 3.5B P/E 2024
43.5x
P/E 2025 56.5x
Enterprise Value 1.83B 19.16M 16.59M 15.52M 14.19M 26.71M 27.16M 182M 71.33M 914M 71.92M 70.37M 3.05B EV / Sales 2024
9.27x
EV / Sales 2025 7.42x
Free-Float
15.47%
Yield 2024 *
-
Yield 2025 -
07-28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
04-29 Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
01-23 Zenotech Laboratories Limited Announces Cessation of Chintan Jitendra Shah as Independent Director, Chairman of the Nomination and Remuneration Committee, Member of Audit Committee/ Stakeholders Relationship Committee and Reconstitution of Board Committees CI
01-23 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
25-10-31 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-25 Zenotech Laboratories Limited Announces Updation of Address of the Registered Office CI
25-07-28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-03-30 Zenotech Laboratories Limited Announces Cessation of Kavita Rakesh Shah as Independent Director, with Effect from April 01, 2025 CI
25-01-28 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
24-10-23 Zenotech Laboratories Limited Appoints Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) CI
24-10-23 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
24-07-26 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
24-05-17 Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024 CI
1 day-0.85%
1 week-0.07%
Current month-0.07%
1 month-1.13%
3 months-5.40%
6 months-4.34%
Current year-3.64%
1 week 43.49
Extreme 43.49
45.9
1 month 43.4
Extreme 43.4
48
Current year 33.55
Extreme 33.55
50.93
1 year 33.55
Extreme 33.55
59
3 years 33.55
Extreme 33.55
107.79
5 years 33.55
Extreme 33.55
107.79
10 years 12
Extreme 12
107.79
Manager TitleAgeSince
Chief Executive Officer - 2024-10-22
Director of Finance/CFO - 2014-02-05
Compliance Officer 46 2016-03-10
Director TitleAgeSince
Director/Board Member 58 2015-07-07
Chairman 67 -
Director/Board Member 42 2016-01-26
Change 5-day change 1-year change 3-year change Capi.($)
-0.85%-0.07%-24.37%-17.62% 28.79M
+3.90%+7.23%+96.91%+134.11% 1,057B
+0.99%+2.13%+51.05%+51.27% 625B
+0.78%-1.18%+25.21%+64.47% 435B
+1.58%+5.51%+51.42%+40.47% 363B
+0.65%+0.16%+34.81%+39.85% 296B
+0.79%-5.08%+9.78%+7.23% 249B
+1.52%+8.32%+44.75%+60.88% 222B
+0.34%-0.11%-5.23%-51.54% 209B
-0.11%+2.19%+11.43%+65.97% 165B
Average +0.96%+2.94%+29.57%+39.51% 362.08B
Weighted average by Cap. +1.78%+4.76%+51.76%+67.33%

Financials

2024 2025
Net sales 368M 3.86M 3.35M 3.13M 2.86M 5.39M 5.48M 36.66M 14.38M 184M 14.5M 14.19M 615M 391M 4.1M 3.55M 3.32M 3.04M 5.72M 5.82M 38.94M 15.27M 196M 15.4M 15.07M 654M
Net income 82.99M 871K 754K 706K 645K 1.21M 1.23M 8.26M 3.24M 41.54M 3.27M 3.2M 139M 56.13M 589K 510K 477K 436K 821K 835K 5.59M 2.19M 28.1M 2.21M 2.16M 93.82M
Net Debt -197M -2.07M -1.79M -1.67M -1.53M -2.88M -2.93M -19.61M -7.69M -98.55M -7.76M -7.59M -329M -267M -2.8M -2.43M -2.27M -2.07M -3.91M -3.97M -26.59M -10.43M -134M -10.52M -10.29M -446M
Logo Zenotech Laboratories Limited
Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company’s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. Its product includes granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
Employees
228
Date Price Change Volume
26-08-10 ₹44.51 -0.85% 3,134
26-08-07 ₹44.89 +1.38% 757
26-08-06 ₹44.28 -0.65% 5,974
26-08-05 ₹44.57 +1.62% 11,657
26-08-04 ₹43.86 -2.27% 2,964
  1. Stock Market
  2. Stocks
  3. ZENOTECH6 Stock